BMO Capital Downgrades Moderna (MRNA) to Market Perform; 'Corona catalysts built in'
Tweet Send to a Friend
(Updated - November 17, 2020 6:45 AM EST)(updated to add analyst comments)BMO Capital analyst George Farmer downgraded Moderna (NASDAQ: MRNA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
